Lee Kalowski
CIK 1618273 · CFO and President · last filed 2026-07-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.39M
Companies
3
Total Filings
30
Lifetime Open-Market Net
-$3.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QTTB | CFO and President | 142,443 | $15.95 | $2.27M | -$57.1K | 7 | 2026-07-20 |
| BCYC | President and CFO | 30,309 | $4.00 | $121.2K | -$2.82M | 16 | 2023-04-05 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Chief Financial Officer | 4,550 | — | — | -$174.5K | 6 | 2015-12-17 |
Recent Filings · Page 2 of 3
30 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-05 | BCYC | Grant (A) | +15,000 | $0 | EDGAR |
| 2021-09-03 | BCYC | Mixed | — | -$301.8K | EDGAR |
| 2021-08-27 | BCYC | Mixed | — | -$224.5K | EDGAR |
| 2021-08-25 | BCYC | Mixed | — | -$235.7K | EDGAR |
| 2021-07-30 | BCYC | Mixed | — | -$373.4K | EDGAR |
| 2021-01-21 | BCYC | Mixed | — | -$426.1K | EDGAR |
| 2021-01-15 | BCYC | Mixed | — | -$234.0K | EDGAR |
| 2021-01-05 | BCYC | Grant (A) | — | $0 | EDGAR |
| 2020-12-03 | BCYC | Mixed | — | -$157.1K | EDGAR |
| 2020-11-30 | BCYC | Mixed | — | -$9.8K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.